Articles tagged with Neurodegenerative Diseases
Developed by CU Anschutz experts, the tool helps patients weigh treatment options and boosts confidence. The majority of patients reported it was helpful in their decision-making process, finding it useful and satisfied with the tool.
Researchers at the University of Edinburgh have developed a method to transform post-consumer plastic into L-DOPA, a frontline medication for Parkinson's disease. The process harnesses the power of bacteria to break down PET waste and produce L-DOPA, providing a sustainable solution to the production of pharmaceuticals.
Researchers found that patients with both conditions exhibited different neuropsychiatric symptoms, which could inform diagnosis and treatment plans. The study's findings may help clinicians better understand the complex disease course of patients with multiple disorders, including Alzheimer's and frontotemporal lobar degeneration.
Researchers tracked daily behaviors of African turquoise killifish for four years, identifying 100 distinct 'behavioral syllables' that predicted lifespan. Fish that lived longer tended to sleep at night, swim with greater vigor, and be more active during daylight hours.
A new study found that functional impairment worsened over time in individuals with early Parkinson's disease, despite plateaued symptoms, with gait, balance, and posture being the most bothersome issues. The study's results underscore the importance of incorporating real-world measures of disease progression in clinical trial design.
Patients with neurological diseases face profound questions about identity, purpose, and meaning, but neurologists often lack training and tools to address these concerns. A new paper offers practical strategies for incorporating spiritual assessment into routine neurological care.
A cancer medication, eFT508, has been shown to lower hyperconnectivity in early Alzheimer's disease by reducing amyloid-beta protein levels. This finding suggests a promising treatment avenue for memory loss in mild cognitive impairment and early Alzheimer's disease.
Researchers discover enzyme ANKIB1 crucial for innate immune signalling, driving type I and type III interferon induction. This finding solves a long-standing puzzle in innate immunity and provides opportunities for new therapies for devastating diseases.
Researchers at Worcester Polytechnic Institute developed an AI tool that analyzes brain scans to predict Alzheimer's disease. The method is accurate in detecting the disease among normal brains and those with mild cognitive impairment, highlighting key anatomical changes such as volume loss in the hippocampus and entorhinal cortex.
Researchers demonstrate that genetically engineered human pluripotent stem cells can overcome immune rejection in mice, surviving for five months with humanized immune systems. The findings provide proof-of-principle for a potential universal donor hPSC line designed to resist immune attack.
Researchers at WashU Medicine have developed a new cellular immunotherapy that uses brain cells called astrocytes to clear away dementia-related proteins, such as amyloid beta. The treatment requires just a single injection and has shown promise in mice by reducing the amount of plaques in half.
A pilot clinical trial suggests that low-dose oral lithium may help slow the decline of verbal memory in older adults with mild cognitive impairment, particularly those with evidence of amyloid beta. The study found that participants receiving lithium showed a slower rate of decline on a sensitive test of verbal memory.
A preliminary study found that people with drinking water from newer groundwater had a higher risk of developing Parkinson's disease. The study suggested that groundwater age and location may be potential environmental risk factors for the disease, with older groundwater from carbonate aquifers showing a protective effect.
Chronic sleep disruption persistently impairs social memory by differentially encoding oxytocin release in hippocampal CA2 during novelty encoding and prelimbic cortex during retrieval of familiar individuals. Restoration of PVN-OXT neurons enhances OXT release and produces sustained behavioral recovery.
Researchers found that noninvasive measures of brain blood flow and oxygenation are associated with hallmark brain changes in older adults with and without cognitive impairment. Higher values on these indicators were linked to lower levels of amyloid plaques and larger hippocampal volume, indicating a lower risk of Alzheimer's disease.
Researchers found NfL levels increase with age in various animals, including mammals, birds, and reptiles. The protein can help assess biological age and predict life expectancy across species.
A new study from Houston Methodist suggests that the outer area of the retina may hold clues to early Alzheimer's detection, potentially allowing for non-invasive diagnosis and monitoring. Researchers found that changes in retinal cells and blood vessels can indicate the onset of AD years before symptoms appear.
Researchers develop novel method to manipulate cell structures using weak magnetic fields and isotopes, bridging structural biology, biophysics, and quantum biology. This work offers a potential new strategy for stabilizing damaged brain proteins, typical of neurodegenerative diseases.
Researchers developed a free-to-use software tool, PSBench, to verify the accuracy of artificial intelligence-based protein structure predictions. The database includes 1.4 million annotated protein models, verified by experts, and provides reliable information for building more accurate AI systems.
Scientists have discovered a mechanism that explains how exercise improves cognition by shoring up the brain's protective barrier. The study found that an exercise-induced liver protein strengthens the blood-brain barrier, reducing inflammation and cognitive decline associated with Alzheimer's disease.
The JAX-NYSCF Collaborative and GSK are working together to develop human cellular models of neurodegenerative diseases. This collaboration aims to generate disease-relevant cellular models that can help scientists understand the underlying biology of neurodegenerative conditions like Alzheimer's disease.
Research finds a specific link between hearing loss and cognitive decline in presbycusis, a neurodegenerative disorder. The Functional-Structural Ratio (FSR) identifies reduced connections between brain areas involved in sound processing and memory, associated with worse hearing thresholds and poorer performance on memory and executive...
Researchers found that Parkinson's patients experience weight loss due to selective fat depletion, not muscle loss, driven by impaired carbohydrate-based energy production. This metabolic shift highlights a disorder of both the brain and body, driving disease progression.
The Biggs Institute will focus on finding solutions to dementia through advanced research, therapies, and care. The new precision therapy center will be named after the donors.
Indiana University scientists have identified IDOL, an enzyme that removes amyloid plaques and improves communication between neurons in the brain. Targeting this enzyme may provide a new way to remove amyloid plaques and improve resilience against disease progression.
Researchers at the University of Michigan School of Public Health found a strong association between bone lead concentrations and increased risk of dementia. The study analyzed data from over 30 years of follow-up and estimated cumulative lifetime exposure to lead using machine learning algorithms.
Researchers have developed an innovative endovascular brain-computer interface (EBCI) that enables precise and minimally invasive diagnosis and treatment of Alzheimer's disease. The EBCI can reach key deep brain regions involved in memory circuits, providing a natural implantation pathway for electrode delivery.
A lattice-like structure called the membrane-associated periodic skeleton (MPS) acts as a gatekeeper for endocytosis, regulating nutrient uptake and protein regulation in brain cells. Disrupting this structure can lead to accelerated endocytosis and increased cellular uptake of toxic molecules like amyloid precursor protein.
A new software tool developed by MIT researchers can reliably and finely resolve eight distinct nerve bundles in live diffusion MRI scans, shedding light on neurodegenerative diseases like Parkinson's and Alzheimer's. The BrainStem Bundle Tool (BSBT) reveals distinct patterns of structural changes in patients with these conditions.
Researchers have identified a specific brain network that is mainly active in the fast beta frequency range and modulates motor symptoms of Parkinson's disease through deep brain stimulation. Stimulating this network, which communicates at 20-35 Hz, can improve motor symptoms in patients with Parkinson's disease.
Researchers at Keck Medicine of USC are investigating a unique therapy that uses lab-generated stem cells to repair damaged brain cells and produce dopamine, which may slow down the progression of Parkinson's disease. The treatment has shown promise in early clinical trials with 12 participants experiencing improved motor function.
Researchers found that altering how alpha-synuclein interacts with LRRK2 limits its ability to bind to cargo and disrupt axonal transport. This suggests a functional link between the two proteins, which may help understand the triggers of Parkinson's disease.
Scientists have discovered a new strategy to prevent the formation of toxic tau tangles in brain cells, which are linked to neurodegenerative diseases. By targeting polyserine, an amino acid chain that drives tau misfolding, researchers have found a potential preventative treatment for tauopathies.
Researchers found that overexpressed Fc gamma receptors on reactive microglia mistakenly identify healthy neurons, leading to their elimination. Immunotherapy targeting these receptors could slow disease progression by preserving dopaminergic neurons.
Researchers at Stanford University discovered that aging brains struggle with protein disposal, leading to the accumulation of damaged proteins in synaptic connections. This finding sheds light on the mechanisms behind neurodegenerative diseases and may lead to new insights into human brain aging.
Researchers at Boston Children's Hospital have developed a novel mass spectrometry tool called FLEXITau to analyze brain tissue from 203 patients with various tauopathies. The study identified 145 post-translational modifications and 195 cleavage sites across tau, providing a precise molecular roadmap for diagnostics and drug development.
Researchers at University College London discovered that Alzheimer's disease disrupts the brain's 'memory replay' process, leading to impaired navigation and memory loss. The study found that even when mice were resting, their brains replayed recent experiences in an altered pattern, which had consequences on memory tasks.
A new study reveals how Parkinson's spreads from the gut to the brain via immune cells, identifying a key role for gut macrophages in transporting toxic proteins. Reducing these cells can slow disease progression and improve motor symptoms in mice.
Two U.S. healthcare systems, Tufts Medicine and University of Utah Health, will implement the DAC-SP Early Detection Blueprint across ten primary care sites to improve early detection of cognitive impairment and Alzheimer's disease. The initiative aims to refine a replicable model for early detection that can be adopted nationwide.
A new study from Lund University finds that modifiable risk factors like smoking and high blood pressure can damage brain blood vessels and increase dementia risk. Living a healthy lifestyle may help delay symptom onset in Alzheimer's disease.
A clinical study will investigate the effects of a three-month at-home intervention with MOVIVE on motor and cognitive responses, utilizing comprehensive assessments and brain imaging techniques. The study aims to inform tailored approaches to assessment and intervention for people with Parkinson's disease.
A multidisciplinary team at USC has developed selective compounds that inhibit an enzyme tied to brain inflammation in people at genetic risk for Alzheimer’s. The inhibitors preserve normal brain function and cross the blood-brain barrier, suggesting a promising therapeutic approach for neurodegenerative diseases.
Dr. Manuel A. Friese has been recognized for his groundbreaking work studying the interactions between inflammation and nerve cell death, which drives disease progression in multiple sclerosis (MS). His research aims to identify new therapeutic targets and bring the field closer to stopping disease progression.
A nationwide study found that Parkinson's disease is more common among individuals with higher socioeconomic status and in the northern provinces of the Netherlands. The risk increases with age, peaking between 75 and 85 years, and is higher among men.
A study reviews decades of research on Hsp70's role in neurodegenerative diseases, highlighting its protective effects and potential therapeutic value. The review reveals that different Hsp70 isoforms interact with co-chaperones and cellular pathways to determine protein clearance.
Research highlights glial cells as dynamic regulators of brain health, playing both protective and harmful roles in neural function. Promising therapeutic targets include oligodendrocyte dysfunction, mitochondrial transfer, and extracellular vesicle engineering.
A team of researchers has discovered a potential new target for treating Parkinson's disease by blocking the interaction between toxic proteins that damages brain cells. The treatment, CS2, improves mobility and cognitive performance in various study models, including human brain tissue and mice models.
Researchers summarize itaconate biology highlighting its chemical reactivity and therapeutic potential in treating infectious diseases, sepsis, autoimmunity, neurodegenerative disorders. Itaconate exerts biological effects through post-translational modifications, altering protein activity and signaling pathways
A new study published in Diabetes, Obesity and Metabolism found that blood sugar spikes after meals may increase the risk of Alzheimer's disease. Individuals with postprandial hyperglycaemia had a 69% greater risk of developing Alzheimer's disease.
The SPINECRAFT project aims to create a cutting-edge, 4D human spinal cord construct that mirrors the architecture and functionality of the real spinal cord. This platform will enable detailed studies of spinal cord biology and integrate patient-derived cells to recreate disease-specific environments.
Researchers highlight shared and distinct immune features between neurodegenerative and neuroimmune diseases, pointing to novel treatment strategies. The study suggests that a deeper understanding of Parkinson's disease immunology informed by lessons from multiple sclerosis may bridge the therapeutic gap for PD.
A study found that increased bone morphogenetic protein signaling is linked to impaired neurogenesis in Alzheimer's disease, particularly in female mice. The research suggests that activation of BMP signaling may be a key factor contributing to the sex-based differences observed in AD.
Researchers at Umea University have identified two autophagy protein complexes as the long-sought sensors of lysosomal damage. These proteins respond to protons or calcium leakage, initiating the repair system that seals the hole, thereby preventing inflammation and cell death.
Researchers found that close to half of all dementia cases would not arise without the APOE gene's influence, and potentially more than 90% of Alzheimer's disease cases are linked to variants in this single gene. The study highlights the APOE gene as a powerful target for drug development.
Researchers found that OTULIN, an enzyme regulating the immune system, drives tau formation and brain inflammation. Deactivating OTULIN halted tau production and removed it from neurons.
A new UCLA study combines human and animal research to identify chlorpyrifos as a potential environmental cause of Parkinson's disease. Long-term residential exposure to the pesticide increases the risk of developing the condition by more than 2.5 times.
A comprehensive review synthesizes emerging evidence on AMPKα isoforms' dual roles in Alzheimer's disease. The analysis proposes that this complexity may explain why pharmacological approaches have yielded mixed results in treating the disease. Isoform-specific targeting is proposed as a novel therapeutic strategy.
Researchers at the University of Illinois discovered that propofol, a common anesthetic agent, can improve cognitive function after surgery in older individuals. Additionally, intranasal insulin was found to mitigate age-related memory impairment by modulating neuroinflammatory mechanisms.